{"id":"elcometrine","rwe":[{"pmid":"30371999","year":"2006","title":"Segesterone Acetate.","finding":"","journal":"","studyType":"Clinical Study"},{"pmid":"17344945","year":"2007","title":"Gateways to clinical trials.","finding":"","journal":"Methods and findings in experimental and clinical pharmacology","studyType":"Clinical Study"},{"pmid":"17235418","year":"2006","title":"Gateways to clinical trials.","finding":"","journal":"Methods and findings in experimental and clinical pharmacology","studyType":"Clinical Study"},{"pmid":"15538546","year":"2004","title":"Gateways to clinical trials.","finding":"","journal":"Methods and findings in experimental and clinical pharmacology","studyType":"Clinical Study"},{"pmid":"15148527","year":"2004","title":"Gateways to clinical trials.","finding":"","journal":"Methods and findings in experimental and clinical pharmacology","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Contraceptive Agents","category":"pharmacology"},{"label":"Contraceptive Agents, Female","category":"pharmacology"},{"label":"Contraceptive Agents, Hormonal","category":"pharmacology"},{"label":"Reproductive Control Agents","category":"pharmacology"}],"phase":"unknown","safety":{},"trials":["NCT04272008","NCT03452111","NCT02994602","NCT04290390","NCT02432261","NCT00229593","NCT00891228","NCT07398924","NCT03432416","NCT02516202","NCT02236026","NCT02215395","NCT02626208","NCT00455156","NCT00263341","NCT01586000","NCT00213096"],"aliases":[],"patents":[],"pricing":[],"allNames":"nestorone","offLabel":[],"synonyms":["elcometrine","nestorone","ST 1435"],"timeline":[],"approvals":[],"brandName":"Nestorone","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body has a lock that progesterone fits into. Nestorone is a key that fits into the same lock, allowing it to turn on the same signals as progesterone. This can help regulate various bodily functions, such as menstrual cycles and pregnancy.","oneSentence":"Nestorone is a progestin that works by binding to and activating the progesterone receptor, mimicking the effects of the hormone progesterone.","technicalDetail":"Nestorone exerts its effects by binding to the progesterone receptor, a nuclear receptor that regulates gene expression in response to progesterone. This binding activates the receptor, leading to changes in gene expression and cellular function."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3175","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=elcometrine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T10:53:52.436381","biosimilars":[],"competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"elcometrine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT04272008","phase":"Phase 1","title":"A Study to Evaluate the Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol","status":"COMPLETED","sponsor":"TherapeuticsMD","isPivotal":false,"enrollment":21,"indication":"Contraception","completionDate":"2021-06-08"},{"nctId":"NCT03452111","phase":"Phase 2","title":"Clinical Evaluation of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception","status":"COMPLETED","sponsor":"Premier Research","isPivotal":false,"enrollment":420,"indication":"Healthy, Men","completionDate":"2024-09-06"},{"nctId":"NCT02994602","phase":"Phase 1","title":"An Open-Label Study of Serum Testosterone and Nestorone in Females After Secondary Exposure to Nestorone ® (NES) + Testosterone (T) Combined Gel Applied to Shoulders and Upper Arms in Males: Effect of","status":"COMPLETED","sponsor":"Kimberly Myer","isPivotal":false,"enrollment":26,"indication":"Healthy Men, Male Contraception","completionDate":"2017-10"},{"nctId":"NCT04290390","phase":"Phase 1","title":"A Drug-Drug Interaction Study to Evaluate the Effects of Strong CYP3A Induction and Inhibition on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol From the Annovera™ Contraceptive Vag","status":"COMPLETED","sponsor":"TherapeuticsMD","isPivotal":false,"enrollment":67,"indication":"Women, Contraception","completionDate":"2021-01-06"},{"nctId":"NCT02432261","phase":"Phase 1","title":"A Randomized, Two Center, Double-Blind Trial to Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Healthy Men","status":"COMPLETED","sponsor":"Kimberly Myer","isPivotal":false,"enrollment":44,"indication":"Healthy","completionDate":"2016-03"},{"nctId":"NCT00229593","phase":"Phase 1","title":"A Randomized, Open Label Clinical Trial to Evaluate if Nestorone Gel Has Gonadotropin Suppressive Activity and if Nestorone in Combination With Testosterone Will Have an Additive Effect on Gonadotropi","status":"COMPLETED","sponsor":"University of Washington","isPivotal":false,"enrollment":140,"indication":"Contraception","completionDate":"2007-01"},{"nctId":"NCT00891228","phase":"Phase 1","title":"A Multicenter, Randomized, Double-Blind Comparator Trial of the Safety and Sperm and Gonadotropin Suppression Resulting From Combined Use of Nestorone® Gel (0, 8 or 12 mg NES) and Testosterone Gel (10","status":"COMPLETED","sponsor":"Premier Research","isPivotal":false,"enrollment":99,"indication":"Contraception","completionDate":"2011-11"},{"nctId":"NCT07398924","phase":"NA","title":"Comparison of Vaginal Estradiol and Oral Guaifenesin Interventions in Patients Undergoing Ovulation Induction With Clomiphene Citrate","status":"COMPLETED","sponsor":"Yuzuncu Yil University","isPivotal":false,"enrollment":90,"indication":"Female Infertility, Anovulatory Infertility","completionDate":"2023-06-23"},{"nctId":"NCT03432416","phase":"Phase 2","title":"A Multicenter, Open-label Randomized Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of Nestorone® and Estradiol (NES-E2 CVR).","status":"COMPLETED","sponsor":"Premier Research","isPivotal":false,"enrollment":385,"indication":"Healthy Women, Female Contraception","completionDate":"2021-12-14"},{"nctId":"NCT02516202","phase":"Phase 3","title":"The Vaginal Health Trial - Effects of Vaginal Estradiol Tablet and Moisturizing Gel on Postmenopausal Vaginal Symptoms","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","isPivotal":true,"enrollment":302,"indication":"Atrophy of Vagina, Menopause","completionDate":"2017-07"},{"nctId":"NCT02236026","phase":"Phase 1","title":"A Double-Blind, Placebo-Controlled, Randomized, Crossover Design Study With an Open-Label Active Control to Evaluate the Potential of Nestorone® to Delay Cardiac Repolarization in Healthy Female Volun","status":"COMPLETED","sponsor":"Population Council","isPivotal":false,"enrollment":44,"indication":"Healthy","completionDate":"2015-12"},{"nctId":"NCT02215395","phase":"Phase 1","title":"Phase 1, Open-label Study to Evaluate the Effects of Concurrent Administration of Vaginal Antimycotic Medication (Miconazole Nitrate) on the Pharmacokinetics of Nestorone and Ethinyl Estradiol Deliver","status":"COMPLETED","sponsor":"Population Council","isPivotal":false,"enrollment":45,"indication":"Antifungal Drug Adverse Reaction","completionDate":"2015-04"},{"nctId":"NCT02626208","phase":"Phase 2","title":"A Dose Finding Study to Evaluate Serum Estradiol Levels With Use of Contraceptive Vaginal Rings Releasing Nestorone® and Escalating Doses of Estradiol in Normal Cycling Women","status":"COMPLETED","sponsor":"Premier Research","isPivotal":false,"enrollment":65,"indication":"Suppression of Ovulation","completionDate":"2017-03"},{"nctId":"NCT00455156","phase":"Phase 3","title":"A Multicenter, Open-label Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of 150µg of Nestorone® and 15µg of Ethinyl Estradiol (150/15 NES/EE CV","status":"COMPLETED","sponsor":"Premier Research","isPivotal":true,"enrollment":1200,"indication":"Contraception","completionDate":"2011-09"},{"nctId":"NCT00263341","phase":"Phase 3","title":"A Multicenter, Open-label Study on the Efficacy, Cycle Control and Safety of a Contraceptive Vaginal Ring Delivering a Daily Dose of 150 ug of Nestorone® and 15 ug of Ethinyl Estradiol","status":"COMPLETED","sponsor":"Population Council","isPivotal":true,"enrollment":1135,"indication":"Contraception","completionDate":"2014-08"},{"nctId":"NCT01586000","phase":"Phase 2","title":"A Dose-finding Study to Evaluate the Effect of a Contraceptive Vaginal Ring, Releasing Nestorone® and Estradiol, on Cycle Control, Ovulation Inhibition, and Pharmacokinetics in Normal Cycling Women","status":"COMPLETED","sponsor":"Kimberly Myer","isPivotal":false,"enrollment":197,"indication":"Suppression of Ovulation","completionDate":"2015-05"},{"nctId":"NCT00213096","phase":"Phase 2","title":"A Randomized, Open-Label Study Comparing the Effect of a Contraceptive Vaginal Ring Delivering Daily Doses of 150 Micrograms Nestorone and 15 Micrograms Ethinyl Estradiol to an Oral Contraceptive Cont","status":"COMPLETED","sponsor":"Population Council","isPivotal":false,"enrollment":50,"indication":"Contraception","completionDate":"2004-02"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"UNII":"9AMX4Q13CC","CHEBI":"CHEBI:135563","UMLSCUI":"C4723397","ChEMBL_ID":"CHEMBL3707377","DRUGBANK_ID":"DB14583","PUBCHEM_CID":"108059","MESH_SUPPLEMENTAL_RECORD_UI":"C029167"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":12,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2006","pmid":"30371999","title":"Segesterone Acetate.","journal":""},{"date":"2007 Jan-Feb","pmid":"17344945","title":"Gateways to clinical trials.","journal":"Methods and findings in experimental and clinical pharmacology"},{"date":"2006 Dec","pmid":"17235418","title":"Gateways to clinical trials.","journal":"Methods and findings in experimental and clinical pharmacology"},{"date":"2004 Sep","pmid":"15538546","title":"Gateways to clinical trials.","journal":"Methods and findings in experimental and clinical pharmacology"},{"date":"2004 Apr","pmid":"15148527","title":"Gateways to clinical trials.","journal":"Methods and findings in experimental and clinical pharmacology"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Nestorone is a small molecule progesterone receptor agonist used in birth control and the treatment of endometriosis. It is available in combination with an estrogen as a vaginal ring or implant, but not effective when taken orally.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}